HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of early and late phase allergic reactions by Euphorbia hirta L.

Abstract
A 95% ethanol extract from whole aerial parts of Euphorbia hirta (EH A001) showed antihistaminic, antiinflammatory and immunosuppressive properties in various animal models. EH A001 inhibited rat peritoneal mast cell degranulation triggered by compound 48/80. It significantly inhibited dextran-induced rat paw edema. EH A001 prevented eosinophil accumulation and eosinophil peroxidase activity and reduced the protein content in bronchoalveolar lavage fluid (BALF) in a 'mild' model of asthma. Moreover, the CD4/CD8 ratio in peripheral blood was suppressed. EH A001 attenuated the release of interleukin-4 (IL-4) and augmented interferon-gamma (IFN-gamma) in ovalbumin-sensitized mouse splenocytes. The results were compared with the effects of known compounds, ketotifen, cetirizine and cyclophosphamide. These findings demonstrated that Euphorbia hirta possessed significant activity to prevent early and late phase allergic reactions.
AuthorsG D Singh, P Kaiser, M S Youssouf, S Singh, A Khajuria, A Koul, S Bani, B K Kapahi, N K Satti, K A Suri, R K Johri
JournalPhytotherapy research : PTR (Phytother Res) Vol. 20 Issue 4 Pg. 316-21 (Apr 2006) ISSN: 0951-418X [Print] England
PMID16557622 (Publication Type: Journal Article)
CopyrightCopyright 2006 John Wiley & Sons, Ltd.
Chemical References
  • Cytokines
  • Histamine Antagonists
  • Plant Extracts
  • Ovalbumin
  • Eosinophil Peroxidase
Topics
  • Animals
  • Bronchoalveolar Lavage Fluid (chemistry)
  • CD4-CD8 Ratio
  • Cytokines (biosynthesis)
  • Edema (drug therapy)
  • Eosinophil Peroxidase (metabolism)
  • Eosinophils (physiology)
  • Euphorbia
  • Histamine Antagonists (analysis)
  • Hypersensitivity (drug therapy, physiopathology)
  • Leukocyte Count
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Ovalbumin
  • Plant Extracts (therapeutic use)
  • Rats
  • Rats, Wistar
  • Spleen (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: